Anthem has no plans of backing away from its plan to buy Cigna in the face of federal opposition, and the Anthem CEO Joseph Swedish said that his company plans to “run out the litigation as long as it takes,” expecting a trial to begin around October.
The health insurer told analysts on July 26 that it is preparing to fight the government’s lawsuit to block its deal, and the company said its participation in the government’s health insurance exchanges may be at stake.
The U.S. Department of Justice sued on July 21 to block both Anthem’s deal and another proposed insurer combination, Aetna’s $34-billion purchase of Humana saying that the deals would reduce competition and raise prices on the exchanges and in other market segments.
These insurance mergers would reduce the nation’s five largest insurers to three.
Full Content: CNBC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Regulators Set to Clear Microsoft’s $13B OpenAI Investment
Apr 17, 2024 by
CPI
Biden Pledges to Block US Steel Acquisition by Japanese Firm
Apr 17, 2024 by
CPI
Canada Targets Tech Titans with New Digital Tax in 2024
Apr 17, 2024 by
CPI
EU Privacy Watchdog Calls for Meta to Offer Ad-Free Option
Apr 17, 2024 by
CPI
Japan’s Antitrust Overhaul Targets Tech Titans Like Apple
Apr 17, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI